secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001140361-26-018464
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 2.03, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology issues $6M promissory note and warrant to YA II PN, redeems existing debentures
--------------------------------------------------------------------------------

- Entered $6M promissory note at 10% interest, 12-month maturity, issued at $5.76M (96% of face).
- Issued warrant for 2,158,274 shares at $1.1824, exercisable after 6 months for 5 years.
- Redeeming existing Senior Secured Convertible Debentures at 103% of principal plus accrued interest on June 12, 2026.
- Terminated prior sales agreement with B. Riley and H.C. Wainwright; entered new ATM with Yorkville Securities.
- Note includes conversion rights upon default at discounted VWAP; warrant has cashless exercise option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/0001140361-26-018464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/ef20072168_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-018464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer